首页 > 最新文献

Health Policy and Technology最新文献

英文 中文
COVID-19 Government policies in Portugal and Brazil: A three-year retrospective analysis COVID-19 葡萄牙和巴西的政府政策:三年回顾分析
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-01 DOI: 10.1016/j.hlpt.2023.100809
Ana Rita Sousa Sequeira , Marta Estrela , Kelsey DeWit

Background

Countries have adopted different COVID-19 policies to contain the transmission of the disease and to prepare for vaccination rollout. Countries’ political context, vaccine policy history, and health systems’ responses impacted COVID-19 health outcomes.

Objective

This study focused on synthesizing and examining COVID-19 non-pharmaceutical interventions in Brazil and Portugal, understanding the enablers and barriers to COVID-19 vaccination access and distribution, and health and non-health outcomes across three time-points: before vaccination, during mass vaccination, and after the declaration of endemicity.

Methods

Extensive qualitative document analysis of secondary sources published in Portuguese and English over the past three years, and examination of primary publicly available epidemiological data since the beginning of the pandemic.

Results

In the first year of the pandemic, the COVID-19 government response between the two countries was dissimilar; effective coordination, trust in the government response and political alignment in Portugal contrasted the political denial of the pandemic, lack of coordination between the various levels of government, at the same time the Brazilian population engaged in protective behaviours and distrusted the government. The COVID-19 vaccination had a good response from the public, associated with a primary care level network of distribution, low vaccine hesitancy, and strong childhood immunization programs before the pandemic in both countries. Vaccine manufacturing in Brazil and the strong support from the European Union to Portugal on vaccine acquisition have also aided these countries in achieving high COVID-19 vaccination coverage.

Conclusion

Future policies to promote a well-functioning and resilient health system should consider medical and nursing workforce sustainability, equity in all policies, building public trust, strengthening health system governance, and improving preparedness and surveillance.

背景各国采取了不同的 COVID-19 政策来遏制该疾病的传播并为疫苗接种做好准备。本研究的重点是综合分析巴西和葡萄牙的 COVID-19 非药物干预措施,了解 COVID-19 疫苗接种和分发的促进因素和障碍,以及在疫苗接种前、大规模疫苗接种期间和宣布地方病流行后三个时间点的健康和非健康结果。方法对过去三年中用葡萄牙语和英语发表的二手资料进行广泛的定性文献分析,并检查自大流行开始以来可公开获得的主要流行病学数据。结果在大流行的第一年,两国政府对 COVID-19 的反应不尽相同;葡萄牙政府有效的协调、对政府反应的信任和政治上的一致形成了鲜明的对比,而巴西政府则在政治上否认大流行,各级政府之间缺乏协调,与此同时,巴西民众采取了保护行为并不信任政府。COVID-19 疫苗接种在公众中反响良好,这与两国在大流行前都建立了初级保健分销网络、疫苗接种犹豫率低和强有力的儿童免疫计划有关。巴西的疫苗生产以及欧盟在疫苗采购方面对葡萄牙的大力支持也帮助这些国家实现了 COVID-19 疫苗的高覆盖率。
{"title":"COVID-19 Government policies in Portugal and Brazil: A three-year retrospective analysis","authors":"Ana Rita Sousa Sequeira ,&nbsp;Marta Estrela ,&nbsp;Kelsey DeWit","doi":"10.1016/j.hlpt.2023.100809","DOIUrl":"10.1016/j.hlpt.2023.100809","url":null,"abstract":"<div><h3>Background</h3><p>Countries have adopted different COVID-19 policies to contain the transmission of the disease and to prepare for vaccination rollout. Countries’ political context, vaccine policy history, and health systems’ responses impacted COVID-19 health outcomes.</p></div><div><h3>Objective</h3><p>This study focused on synthesizing and examining COVID-19 non-pharmaceutical interventions in Brazil and Portugal, understanding the enablers and barriers to COVID-19 vaccination access and distribution, and health and non-health outcomes across three time-points: before vaccination, during mass vaccination, and after the declaration of endemicity.</p></div><div><h3>Methods</h3><p>Extensive qualitative document analysis of secondary sources published in Portuguese and English over the past three years, and examination of primary publicly available epidemiological data since the beginning of the pandemic.</p></div><div><h3>Results</h3><p>In the first year of the pandemic, the COVID-19 government response between the two countries was dissimilar; effective coordination, trust in the government response and political alignment in Portugal contrasted the political denial of the pandemic, lack of coordination between the various levels of government, at the same time the Brazilian population engaged in protective behaviours and distrusted the government. The COVID-19 vaccination had a good response from the public, associated with a primary care level network of distribution, low vaccine hesitancy, and strong childhood immunization programs before the pandemic in both countries. Vaccine manufacturing in Brazil and the strong support from the European Union to Portugal on vaccine acquisition have also aided these countries in achieving high COVID-19 vaccination coverage.</p></div><div><h3>Conclusion</h3><p>Future policies to promote a well-functioning and resilient health system should consider medical and nursing workforce sustainability, equity in all policies, building public trust, strengthening health system governance, and improving preparedness and surveillance.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100809"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000850/pdfft?md5=bfb85ba953c7fd3c1d8b33778fddcd7c&pid=1-s2.0-S2211883723000850-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135427895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are we past the COVID-19 Pandemic? Insights from Singapore 我们是否已经度过了COVID-19大流行?新加坡的启示
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-01 DOI: 10.1016/j.hlpt.2023.100779
Angela Wong , Claudia Zoller , Ayman Fouda , Francesco Paolucci

Objective

This study aims to examine the interplay between high policy stringency, vaccination rates and epidemiological outcomes to develop insights on COVID-19 policy transition in Singapore

Methods

The CPTI (Categorising Policy & Technology Interventions) framework was used to classify reported interventions from January 2021 to October 2022. To analyse the impact of vaccine measures, an additional category was created. The highest monthly proportion of de-escalated measures was used as a basis to define the periods that mark the policy transition in Singapore i.e. Phase 2 and 3. Proportions of significantly escalated measures were calculated and analysed against full and booster vaccination rates, alongside epidemiological indicators – monthly total number of infections and deaths, and monthly average active hospitalisation and ICU cases.

Results

Implementation of highly stringent policies were observed to have reduced in intensity as vaccination rates picked up from Phase 2 to 3. Containment measures were the most frequently and consistently adopted beside vaccine policies. Epidemiological indicators appeared to be generally lower in Phase 3 than Phase 2. Specifically, despite reduced intensity of stringent polices, hospitalisation and ICU cases were observed to remain relatively low when vaccination rates were correspondingly higher in Phase 3 compared to Phase 2.

Conclusion

The descriptive analysis of COVID-19 policy shift in Singapore based on selected indicators preliminarily suggested its successful transition from the pandemic to endemic phase in its response strategies. A policy transition plan should consider the significance of vaccination rates in an exit strategy that protects the population against worse health outcomes.

方法 采用 CPTI(政策与amp;技术干预分类)框架对 2021 年 1 月至 2022 年 10 月期间报告的干预措施进行分类。为了分析疫苗措施的影响,我们创建了一个额外的类别。每月最高的降级措施比例被用来定义新加坡的政策过渡时期,即第二和第三阶段。结果发现,随着疫苗接种率从第 2 阶段上升到第 3 阶段,实施高度严格政策的力度有所减弱。 除疫苗政策外,遏制措施也是最经常和最持续采用的措施。第 3 阶段的流行病学指标似乎普遍低于第 2 阶段。具体而言,尽管严格政策的力度有所减弱,但在第三阶段,当疫苗接种率相应高于第二阶段时,住院病例和重症监护病房病例仍保持在较低水平。政策过渡计划应考虑疫苗接种率在退出战略中的重要性,以保护民众免受更坏的健康结果影响。
{"title":"Are we past the COVID-19 Pandemic? Insights from Singapore","authors":"Angela Wong ,&nbsp;Claudia Zoller ,&nbsp;Ayman Fouda ,&nbsp;Francesco Paolucci","doi":"10.1016/j.hlpt.2023.100779","DOIUrl":"10.1016/j.hlpt.2023.100779","url":null,"abstract":"<div><h3>Objective</h3><p>This study aims to examine the interplay between high policy stringency, vaccination rates and epidemiological outcomes to develop insights on COVID-19 policy transition in Singapore</p></div><div><h3>Methods</h3><p>The CPTI (Categorising Policy &amp; Technology Interventions) framework was used to classify reported interventions from January 2021 to October 2022. To analyse the impact of vaccine measures, an additional category was created. The highest monthly proportion of de-escalated measures was used as a basis to define the periods that mark the policy transition in Singapore i.e. Phase 2 and 3. Proportions of significantly escalated measures were calculated and analysed against full and booster vaccination rates, alongside epidemiological indicators – monthly total number of infections and deaths, and monthly average active hospitalisation and ICU cases.</p></div><div><h3>Results</h3><p>Implementation of highly stringent policies were observed to have reduced in intensity as vaccination rates picked up from Phase 2 to 3. Containment measures were the most frequently and consistently adopted beside vaccine policies. Epidemiological indicators appeared to be generally lower in Phase 3 than Phase 2. Specifically, despite reduced intensity of stringent polices, hospitalisation and ICU cases were observed to remain relatively low when vaccination rates were correspondingly higher in Phase 3 compared to Phase 2.</p></div><div><h3>Conclusion</h3><p>The descriptive analysis of COVID-19 policy shift in Singapore based on selected indicators preliminarily suggested its successful transition from the pandemic to endemic phase in its response strategies. A policy transition plan should consider the significance of vaccination rates in an exit strategy that protects the population against worse health outcomes.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100779"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000552/pdfft?md5=89c380f51b12f1cd14ee67d4a79ffb64&pid=1-s2.0-S2211883723000552-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43887302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination and non-pharmaceutical interventions during COVID-19: Impact on health and non-health outcomes in the US 新冠肺炎期间的疫苗接种和非药物干预:对美国健康和非健康结果的影响
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-01 DOI: 10.1016/j.hlpt.2023.100792
Asmita P. Khatiwada , Mesfin G. Genie , Aregawi G. Gebremariam , Tim C. Lai , Nabin Poudel , Surachat Ngorsuraches

Objective

Little is known about the relative effectiveness of COVID-19 vaccination and its interaction with non-pharmaceutical interventions (NPIs) in reducing infections, deaths, COVID-19 reproduction rate, and job losses. This study examined the relative effectiveness of vaccination and NPIs on COVID-19 infection, deaths, reproduction rate, and unemployment rate in the US.

Methods

Retrospective US data at the national level were obtained from the Oxford COVID-19 Government Response Tracker (OxCGRT dataset). Unemployment rate data were obtained from the US Bureau of Labor Statistics. Time-trend analyses of the policy variables and epidemiological outcomes were performed. A regression discontinuity in time was used to investigate the effects of policy variables on health outcomes and unemployment rate.

Results

Based on time-trend analyses, the number of people vaccinated increased starting in March 2021, while the stringency index had steadily declined since early January 2021. A decrease in new COVID-19 cases and deaths was observed during this period. However, despite higher vaccination coverage, new COVID-19 cases and deaths peaked in late 2021 and early 2022. We found that the interaction between treatment effects (vaccinations) and stringency measures was negatively associated with total COVID-19 cases and deaths, implying that some restrictions might be required to reduce rising infections during vaccination campaigns. We also found a negative association between vaccinations and the unemployment rate.

Conclusion

The study findings suggested that vaccinations alone were insufficient to reduce virus spread and deaths, and that some NPIs might be required during the vaccination campaigns.

目标人们对 COVID-19 疫苗接种及其与非药物干预措施(NPIs)在降低感染率、死亡率、COVID-19 繁殖率和失业率方面的相互作用的相对效果知之甚少。本研究探讨了接种疫苗和非药物干预措施对美国 COVID-19 感染、死亡、繁殖率和失业率的相对效果。方法美国全国范围内的回顾性数据来自牛津 COVID-19 政府响应追踪系统(OxCGRT 数据集)。失业率数据来自美国劳工统计局。对政策变量和流行病学结果进行了时间趋势分析。结果根据时间趋势分析,接种疫苗的人数从 2021 年 3 月开始增加,而接种严格指数从 2021 年 1 月初开始稳步下降。在此期间,COVID-19 新发病例和死亡人数均有所下降。然而,尽管疫苗接种覆盖率提高了,COVID-19 新发病例和死亡人数仍在 2021 年底和 2022 年初达到高峰。我们发现,治疗效果(疫苗接种)与严格措施之间的交互作用与 COVID-19 病例和死亡总数呈负相关,这意味着可能需要采取一些限制措施来减少疫苗接种活动期间感染率的上升。我们还发现疫苗接种与失业率之间存在负相关关系。结论研究结果表明,仅靠疫苗接种不足以减少病毒传播和死亡人数,在疫苗接种过程中可能需要采取一些非强制性措施。
{"title":"Vaccination and non-pharmaceutical interventions during COVID-19: Impact on health and non-health outcomes in the US","authors":"Asmita P. Khatiwada ,&nbsp;Mesfin G. Genie ,&nbsp;Aregawi G. Gebremariam ,&nbsp;Tim C. Lai ,&nbsp;Nabin Poudel ,&nbsp;Surachat Ngorsuraches","doi":"10.1016/j.hlpt.2023.100792","DOIUrl":"10.1016/j.hlpt.2023.100792","url":null,"abstract":"<div><h3>Objective</h3><p>Little is known about the relative effectiveness of COVID-19 vaccination and its interaction with non-pharmaceutical interventions (NPIs) in reducing infections, deaths, COVID-19 reproduction rate, and job losses. This study examined the relative effectiveness of vaccination and NPIs on COVID-19 infection, deaths, reproduction rate, and unemployment rate in the US.</p></div><div><h3>Methods</h3><p>Retrospective US data at the national level were obtained from the Oxford COVID-19 Government Response Tracker (OxCGRT dataset). Unemployment rate data were obtained from the US Bureau of Labor Statistics. Time-trend analyses of the policy variables and epidemiological outcomes were performed. A regression discontinuity in time was used to investigate the effects of policy variables on health outcomes and unemployment rate.</p></div><div><h3>Results</h3><p>Based on time-trend analyses, the number of people vaccinated increased starting in March 2021, while the stringency index had steadily declined since early January 2021. A decrease in new COVID-19 cases and deaths was observed during this period. However, despite higher vaccination coverage, new COVID-19 cases and deaths peaked in late 2021 and early 2022. We found that the interaction between treatment effects (vaccinations) and stringency measures was negatively associated with total COVID-19 cases and deaths, implying that some restrictions might be required to reduce rising infections during vaccination campaigns. We also found a negative association between vaccinations and the unemployment rate.</p></div><div><h3>Conclusion</h3><p>The study findings suggested that vaccinations alone were insufficient to reduce virus spread and deaths, and that some NPIs might be required during the vaccination campaigns.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100792"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000680/pdfft?md5=692402b6a561e3282d83f2f039f7c768&pid=1-s2.0-S2211883723000680-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49564409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interplay between global health policy and vaccination strategies in the shift towards COVID-19 endemicity 全球卫生政策与疫苗接种战略之间在科维德-19 流行率变化中的相互作用
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-01 DOI: 10.1016/j.hlpt.2024.100854
Marcello Antonini , Ayman Fouda , Madeleine Hinwood , Adrian Melia , Francesco Paolucci
{"title":"The interplay between global health policy and vaccination strategies in the shift towards COVID-19 endemicity","authors":"Marcello Antonini ,&nbsp;Ayman Fouda ,&nbsp;Madeleine Hinwood ,&nbsp;Adrian Melia ,&nbsp;Francesco Paolucci","doi":"10.1016/j.hlpt.2024.100854","DOIUrl":"10.1016/j.hlpt.2024.100854","url":null,"abstract":"","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100854"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883724000170/pdfft?md5=4fcbe34afc1cf0ab64a3f366cd71fc01&pid=1-s2.0-S2211883724000170-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139883744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 in the Netherlands: A three-phase analysis 荷兰的新冠肺炎:三阶段分析
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-01 DOI: 10.1016/j.hlpt.2023.100783
Anouk van Amerongen , Claudia Zoller , Ayman Fouda

Introduction

The COVID-19 pandemic has presented global challenges in the health, economy, society, and political sector for the past three years. For the Netherlands, the dynamic nature of the pandemic can be divided into three phases. The initial phase exclusively relied on non-pharmaceutical interventions (NPIs). The second phase was characterized by the introduction of vaccines alongside the continuation of stringent NPIs. Finally, the third phase marks the post-vaccine and booster stage, characterized by minimal or absent NPIs. This paper examines the interplay between the mitigation policies, the vaccination rollout, health outcomes, and economic indicators in the Netherlands in these three phases.

Methods

This analysis used national real-time data on COVID-19-related health outcomes, health service utilization, vaccination rollout, and economic indicators. Our descriptive analysis applied the “Categorising Policy & Technology Interventions (CPTI)” framework.

Results

The number of daily deaths, hospital admission and ICU admission experienced the highest peak in the first phase, while the number of daily cases first spiked in the third phase. The containment measures reached a very significant level twice, resulting in a full lockdown twice. In the first two phases, the peak in stringency of the CPTI containment category was parallel with the peaks in health outcomes. Conversely, in the third phase, the containment measures were scaled down prior to the peak in daily cases.

Conclusions

Our findings suggest that the Dutch three-phased COVID-19 mitigation strategy managed to fulfil its aim and protect vulnerable individuals, prevent healthcare institutions from overload, and move from the pandemic to the endemic phase.

导言在过去的三年里,COVID-19 大流行病给卫生、经济、社会和政治领域带来了全球性挑战。对荷兰而言,大流行病的动态性质可分为三个阶段。最初阶段完全依靠非药物干预措施(NPIs)。第二阶段的特点是在继续实施严格的非药物干预措施的同时引入疫苗。最后,第三阶段是疫苗接种后和强化阶段,其特点是极少或没有非药物干预措施。本文研究了荷兰在这三个阶段中减灾政策、疫苗接种推广、健康结果和经济指标之间的相互作用。方法本分析使用了 COVID-19 相关健康结果、医疗服务利用率、疫苗接种推广和经济指标的全国实时数据。我们的描述性分析采用了 "政策与产品分类;技术干预(CPTI)"框架。结果在第一阶段,每日死亡人数、入院人数和入住重症监护室人数达到了最高峰,而每日病例数在第三阶段首次激增。遏制措施两次达到非常高的水平,导致两次全面封锁。在前两个阶段,CPTI 遏制类别的严格程度峰值与健康结果的峰值平行。结论我们的研究结果表明,荷兰分三个阶段实施的 COVID-19 缓解战略成功地实现了其目标,保护了易感人群,防止了医疗机构超负荷工作,并从大流行阶段进入了地方病阶段。
{"title":"COVID-19 in the Netherlands: A three-phase analysis","authors":"Anouk van Amerongen ,&nbsp;Claudia Zoller ,&nbsp;Ayman Fouda","doi":"10.1016/j.hlpt.2023.100783","DOIUrl":"10.1016/j.hlpt.2023.100783","url":null,"abstract":"<div><h3>Introduction</h3><p>The COVID-19 pandemic has presented global challenges in the health, economy, society, and political sector for the past three years. For the Netherlands, the dynamic nature of the pandemic can be divided into three phases. The initial phase exclusively relied on non-pharmaceutical interventions (NPIs). The second phase was characterized by the introduction of vaccines alongside the continuation of stringent NPIs. Finally, the third phase marks the post-vaccine and booster stage, characterized by minimal or absent NPIs. This paper examines the interplay between the mitigation policies, the vaccination rollout, health outcomes, and economic indicators in the Netherlands in these three phases.</p></div><div><h3>Methods</h3><p>This analysis used national real-time data on COVID-19-related health outcomes, health service utilization, vaccination rollout, and economic indicators. Our descriptive analysis applied the “Categorising Policy &amp; Technology Interventions (CPTI)” framework.</p></div><div><h3>Results</h3><p>The number of daily deaths, hospital admission and ICU admission experienced the highest peak in the first phase, while the number of daily cases first spiked in the third phase. The containment measures reached a very significant level twice, resulting in a full lockdown twice. In the first two phases, the peak in stringency of the CPTI containment category was parallel with the peaks in health outcomes. Conversely, in the third phase, the containment measures were scaled down prior to the peak in daily cases.</p></div><div><h3>Conclusions</h3><p>Our findings suggest that the Dutch three-phased COVID-19 mitigation strategy managed to fulfil its aim and protect vulnerable individuals, prevent healthcare institutions from overload, and move from the pandemic to the endemic phase.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100783"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221188372300059X/pdfft?md5=5bda2b559d9531a5cbdb9d7cbaab7ac1&pid=1-s2.0-S221188372300059X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47607647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating economic turmoil: Chilean businesses during COVID-19 lockdowns and vaccine rollouts 驾驭经济动荡:在 COVID-19 封锁和疫苗推广期间的智利企业
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-03-01 DOI: 10.1016/j.hlpt.2023.100813
Julio A. Pertuze , José Pablo Montégu , Cecilia González , Rafael Araos , Paula Daza

Objectives

This study evaluates the effects of COVID-19 lockdowns, differentiated by their stringency, on the sales of Chilean businesses across various size categories and industries throughout 2020 and 2021. It also explores the role of the vaccination campaign and the implementation of the Mobility Pass in mitigating the negative economic effects of stringent containment measures.

Methods

The study uses administrative data from the Chilean Internal Revenue Service (SII), examining sales across different business sizes and industries, from March 2020 to December 2021. Through an econometric analysis, we estimate the effects of lockdowns on business sales during two distinct periods: initial reliance on dynamic non-pharmaceutical interventions (NPIs) pre-vaccine, and a subsequent stage characterized by high vaccine uptake and reduced NPI stringency.

Results

Lockdowns significantly reduced sales across all business sizes and most industries during the first period, with microenterprises and certain service sectors experiencing the highest decline. The national vaccination campaign and the introduction of the Mobility Pass in the second period appears to have mitigated the negative effects of lockdowns, primarily benefiting micro and small firms.

Conclusions

The study highlights the trade-offs between health and economic outcomes during the pandemic, stressing the importance to alleviate mobility restrictions post-vaccine rollout to ease the economic strain on businesses. The findings call for targeted support measures for MSMEs and vulnerable industries affected by NPIs.

本研究评估了 COVID-19 封锁在 2020 年和 2021 年对智利不同规模类别和行业的企业销售额的影响。研究还探讨了疫苗接种活动和移动通行证的实施在减轻严格封锁措施的负面经济影响方面所起的作用。研究方法本研究使用智利国内税收署(SII)的行政数据,考察了 2020 年 3 月至 2021 年 12 月期间不同规模和行业的企业销售情况。通过计量经济学分析,我们估算了两个不同时期封锁对企业销售额的影响:疫苗接种前对动态非药物干预措施(NPIs)的最初依赖,以及以疫苗接种率高和非药物干预措施严格程度降低为特征的随后阶段。结果在第一阶段,封锁显著降低了所有企业规模和大多数行业的销售额,其中微型企业和某些服务行业的降幅最大。在第二阶段,全国疫苗接种活动和流动通行证的推出似乎减轻了封锁的负面影响,主要惠及微型和小型企业。结论该研究强调了大流行期间健康和经济成果之间的权衡,强调了在疫苗推出后减轻流动限制以缓解企业经济压力的重要性。研究结果呼吁对受非典型肺炎影响的中小微企业和脆弱行业采取有针对性的支持措施。
{"title":"Navigating economic turmoil: Chilean businesses during COVID-19 lockdowns and vaccine rollouts","authors":"Julio A. Pertuze ,&nbsp;José Pablo Montégu ,&nbsp;Cecilia González ,&nbsp;Rafael Araos ,&nbsp;Paula Daza","doi":"10.1016/j.hlpt.2023.100813","DOIUrl":"10.1016/j.hlpt.2023.100813","url":null,"abstract":"<div><h3>Objectives</h3><p>This study evaluates the effects of COVID-19 lockdowns, differentiated by their stringency, on the sales of Chilean businesses across various size categories and industries throughout 2020 and 2021. It also explores the role of the vaccination campaign and the implementation of the Mobility Pass in mitigating the negative economic effects of stringent containment measures.</p></div><div><h3>Methods</h3><p>The study uses administrative data from the Chilean Internal Revenue Service (SII), examining sales across different business sizes and industries, from March 2020 to December 2021. Through an econometric analysis, we estimate the effects of lockdowns on business sales during two distinct periods: initial reliance on dynamic non-pharmaceutical interventions (NPIs) pre-vaccine, and a subsequent stage characterized by high vaccine uptake and reduced NPI stringency.</p></div><div><h3>Results</h3><p>Lockdowns significantly reduced sales across all business sizes and most industries during the first period, with microenterprises and certain service sectors experiencing the highest decline. The national vaccination campaign and the introduction of the Mobility Pass in the second period appears to have mitigated the negative effects of lockdowns, primarily benefiting micro and small firms.</p></div><div><h3>Conclusions</h3><p>The study highlights the trade-offs between health and economic outcomes during the pandemic, stressing the importance to alleviate mobility restrictions post-vaccine rollout to ease the economic strain on businesses. The findings call for targeted support measures for MSMEs and vulnerable industries affected by NPIs.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"13 1","pages":"Article 100813"},"PeriodicalIF":6.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000898/pdfft?md5=f9c5f0284ed129531c147f26758177de&pid=1-s2.0-S2211883723000898-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134995166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to ‘Towards a universal patient-centric health record sharing platform’ [Health Policy and Technology 12 (2023) 100819] “迈向以患者为中心的通用健康记录共享平台”的勘误表[卫生政策与技术12 (2023)100819]
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-11-18 DOI: 10.1016/j.hlpt.2023.100821
Mana Azarm , Rebecca Meehan , Craig Kuziemsky

Abstract

摘要。
{"title":"Corrigendum to ‘Towards a universal patient-centric health record sharing platform’ [Health Policy and Technology 12 (2023) 100819]","authors":"Mana Azarm ,&nbsp;Rebecca Meehan ,&nbsp;Craig Kuziemsky","doi":"10.1016/j.hlpt.2023.100821","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100821","url":null,"abstract":"<div><p>Abstract</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100821"},"PeriodicalIF":6.0,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723000977/pdfft?md5=0b347d243a5a26d272b0236c8b84f9e6&pid=1-s2.0-S2211883723000977-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138453984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to ‘Machine learning prediction of hospital patient need for post-acute care using an admission mobility measure is robust across patient diagnoses’ [Health Policy and Technology 12 (2023) 100,754] “使用入院流动性措施对医院患者急性后护理需求的机器学习预测在患者诊断中是稳健的”[卫生政策与技术12(2023)100,754]的勘误表
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-11-18 DOI: 10.1016/j.hlpt.2023.100825
Daniel L. Young , Rebecca Engels , Elizabeth Colantuoni , Lisa Aronson Friedman , Erik H. Hoyer

None

没有一个
{"title":"Corrigendum to ‘Machine learning prediction of hospital patient need for post-acute care using an admission mobility measure is robust across patient diagnoses’ [Health Policy and Technology 12 (2023) 100,754]","authors":"Daniel L. Young ,&nbsp;Rebecca Engels ,&nbsp;Elizabeth Colantuoni ,&nbsp;Lisa Aronson Friedman ,&nbsp;Erik H. Hoyer","doi":"10.1016/j.hlpt.2023.100825","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100825","url":null,"abstract":"<div><p>None</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100825"},"PeriodicalIF":6.0,"publicationDate":"2023-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2211883723001016/pdfft?md5=127e2af5e8991d39e0edc980c50fad49&pid=1-s2.0-S2211883723001016-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138453983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial intelligence for patient scheduling in the real-world health care setting: A metanarrative review 人工智能患者调度在现实世界的医疗保健设置:元叙述回顾
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-11-12 DOI: 10.1016/j.hlpt.2023.100824
Dacre R.T. Knight , Christopher A. Aakre , Christopher V. Anstine , Bala Munipalli , Parisa Biazar , Ghada Mitri , Jose Raul Valery , Tara Brigham , Shehzad K. Niazi , Adam I. Perlman , John D. Halamka , Abd Moain Abu Dabrh
<div><h3>Objectives</h3><p>The application of artificial intelligence (AI) and machine learning (ML) to scheduling in medical practices has considerable implications for most specialties. However, the landscape of AI and ML use in scheduling optimization is unclear. We aimed to systematically summarize up-to-date evidence about application of AI and ML models for scheduling optimization in clinical settings.</p></div><div><h3>Methods</h3><p><span>We systematically searched multiple databases from inception through August 2020 to identify studies that described real-world application of AI and ML in health care scheduling and reported outcomes. Eligible studies included those conducted in any health care setting using ML or </span>predictive modeling through AI to optimize patient scheduling processes in real-time, real-world settings. Outcomes of interest included assessing impact on stakeholders (i.e., providers, patients, health systems), including impact on workload, burden, burnout, cost, utilization, patient and provider satisfaction, waste reduction, and quality. Data were extracted and reviewed in duplicates, independently and blindly by two reviewers. The results were synthesized and summarized using a metanarrative approach.</p></div><div><h3>Results</h3><p>The initial search strategy yielded 3,415 citations, of which 11 eligible studies were included. Outcome measures for studies on missed appointments covered patient double-booking volume, missed appointments, service use, and missed appointment risk. Resource allocation outcomes assessed wait time, disease-type matching performance, schedule efficiency revenue, and new patient volume wait time. Other outcomes included visit requests, examination length prediction, and surgical case time.</p></div><div><h3>Conclusions</h3><p>Available evidence shows heterogeneity in the stages of AI and ML development as they apply to patient scheduling. AI and ML applications can be used to decrease the burden on provider time, increase patient satisfaction, and ultimately provide more patient-directed health care and efficiency for medical practices. These findings help identify additional opportunities in which AI platforms can be developed to optimize patient scheduling.</p></div><div><h3>Public Interest Summary</h3><p><span>Artificial Intelligence (AI) and machine learning (ML) can help many aspects of health care. Patient scheduling has significant implications for the cost benefits of improved technology. The longstanding use of technology in medicine serves as a strong foundation for future AI applications. Here, we present an up-to-date review of the current use of AI and ML for schedule optimization in the health care clinic setting. Current evidence shows a wide variety of stages in the development, function, and application of AI and ML </span>in patient scheduling. Given the current gaps of knowledge, future studies should address feasibility, effectiveness, generalizability, and risk of A
目的人工智能(AI)和机器学习(ML)在医疗实践调度中的应用对大多数专业都有相当大的影响。然而,人工智能和机器学习在调度优化中的应用前景尚不明朗。我们的目的是系统地总结有关人工智能和机器学习模型在临床设置调度优化中的应用的最新证据。方法我们系统地检索了从成立到2020年8月的多个数据库,以确定描述AI和ML在医疗保健计划和报告结果中的实际应用的研究。符合条件的研究包括在任何医疗保健环境中使用ML或通过人工智能进行预测建模,以优化实时、现实环境中的患者调度流程的研究。感兴趣的结果包括评估对利益相关者(即提供者、患者、卫生系统)的影响,包括对工作量、负担、倦怠、成本、利用率、患者和提供者满意度、减少浪费和质量的影响。两名审稿人独立、盲目地重复提取和审查数据。使用元叙事方法对结果进行综合和总结。结果最初的搜索策略产生了3415条引用,其中包括11项符合条件的研究。错过预约研究的结果指标包括患者重复预约量、错过预约、服务使用和错过预约风险。资源分配结果评估了等待时间、疾病类型匹配性能、计划效率收入和新患者数量等待时间。其他结果包括访问请求、检查时间预测和手术病例时间。结论现有证据表明,人工智能和机器学习发展阶段在患者调度方面存在异质性。人工智能和机器学习应用程序可用于减少提供者的时间负担,提高患者满意度,并最终为医疗实践提供更多以患者为导向的医疗保健和效率。这些发现有助于确定开发人工智能平台以优化患者日程安排的其他机会。人工智能(AI)和机器学习(ML)可以在医疗保健的许多方面提供帮助。患者日程安排对改进技术的成本效益具有重要意义。技术在医学中的长期应用为未来的人工智能应用奠定了坚实的基础。在这里,我们介绍了目前在卫生保健诊所设置中使用人工智能和机器学习进行时间表优化的最新综述。目前的证据表明,人工智能和机器学习在患者调度中的发展、功能和应用处于各种各样的阶段。鉴于目前的知识差距,未来的研究应解决人工智能在患者安排中的可行性、有效性、普遍性和风险。
{"title":"Artificial intelligence for patient scheduling in the real-world health care setting: A metanarrative review","authors":"Dacre R.T. Knight ,&nbsp;Christopher A. Aakre ,&nbsp;Christopher V. Anstine ,&nbsp;Bala Munipalli ,&nbsp;Parisa Biazar ,&nbsp;Ghada Mitri ,&nbsp;Jose Raul Valery ,&nbsp;Tara Brigham ,&nbsp;Shehzad K. Niazi ,&nbsp;Adam I. Perlman ,&nbsp;John D. Halamka ,&nbsp;Abd Moain Abu Dabrh","doi":"10.1016/j.hlpt.2023.100824","DOIUrl":"10.1016/j.hlpt.2023.100824","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objectives&lt;/h3&gt;&lt;p&gt;The application of artificial intelligence (AI) and machine learning (ML) to scheduling in medical practices has considerable implications for most specialties. However, the landscape of AI and ML use in scheduling optimization is unclear. We aimed to systematically summarize up-to-date evidence about application of AI and ML models for scheduling optimization in clinical settings.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;p&gt;&lt;span&gt;We systematically searched multiple databases from inception through August 2020 to identify studies that described real-world application of AI and ML in health care scheduling and reported outcomes. Eligible studies included those conducted in any health care setting using ML or &lt;/span&gt;predictive modeling through AI to optimize patient scheduling processes in real-time, real-world settings. Outcomes of interest included assessing impact on stakeholders (i.e., providers, patients, health systems), including impact on workload, burden, burnout, cost, utilization, patient and provider satisfaction, waste reduction, and quality. Data were extracted and reviewed in duplicates, independently and blindly by two reviewers. The results were synthesized and summarized using a metanarrative approach.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;p&gt;The initial search strategy yielded 3,415 citations, of which 11 eligible studies were included. Outcome measures for studies on missed appointments covered patient double-booking volume, missed appointments, service use, and missed appointment risk. Resource allocation outcomes assessed wait time, disease-type matching performance, schedule efficiency revenue, and new patient volume wait time. Other outcomes included visit requests, examination length prediction, and surgical case time.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;p&gt;Available evidence shows heterogeneity in the stages of AI and ML development as they apply to patient scheduling. AI and ML applications can be used to decrease the burden on provider time, increase patient satisfaction, and ultimately provide more patient-directed health care and efficiency for medical practices. These findings help identify additional opportunities in which AI platforms can be developed to optimize patient scheduling.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Public Interest Summary&lt;/h3&gt;&lt;p&gt;&lt;span&gt;Artificial Intelligence (AI) and machine learning (ML) can help many aspects of health care. Patient scheduling has significant implications for the cost benefits of improved technology. The longstanding use of technology in medicine serves as a strong foundation for future AI applications. Here, we present an up-to-date review of the current use of AI and ML for schedule optimization in the health care clinic setting. Current evidence shows a wide variety of stages in the development, function, and application of AI and ML &lt;/span&gt;in patient scheduling. Given the current gaps of knowledge, future studies should address feasibility, effectiveness, generalizability, and risk of A","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100824"},"PeriodicalIF":6.0,"publicationDate":"2023-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135713776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A national survey of physicians regarding protection of patient privacy in China 一项关于中国医生对患者隐私保护的全国性调查
IF 6 3区 医学 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-11-10 DOI: 10.1016/j.hlpt.2023.100823
Zhongzhou Xiao , Wei Zhai , Xinwei Peng , Yun Zhong , Shuqing Luo , Ruiyao Chen , Lu Lu , Yijue Zhang , Jie Xu
<div><h3><strong>Objectives</strong></h3><p>The significance of safeguarding patient privacy at a population level within public medical institutions remains insufficiently acknowledged despite the potential to enhance the protection awareness of physicians and of hospital management in clinical practice. We herein devised a survey to investigate the current state of patient privacy breaches in China and to ascertain its underlying rationales.</p></div><div><h3><strong>Methods</strong></h3><p><span>We conducted a comprehensive nationwide survey of 928 physicians in seven geographic regions of China through convenience and snowball sampling, enrolled physicians defined in the Chinese Health Statistics Yearbook, and measured the incidence of medical data breaches. Physicians’ perceptions and behaviors with respect to patient privacy protection and their attitudes toward hospital management were accessed through descriptive statistics. Multiple </span>logistic regression analysis was also conducted with different adjustments of covariates for each model.</p></div><div><h3><strong>Results</strong></h3><p>Of the 937 respondents, 928 physicians were eligible and validated for the analysis. We estimated that 52.2 % (95 %CI, 48.9–55.4) of the physicians reported that they had disclosed their patients’ privacy. Master's (OR, 0.63 [95 %CI, 0.43–0.92]) and Ph.D. (OR, 0.59 [95 %CI, 0.35–1.00]) educational levels, scores on the understanding of patient privacy protection (OR, 0.89 [95 %CI, 0.80–0.99]), the presence of colleagues who had experienced data disclosure (OR, 7.00 [95 %CI, 5.02–9.77]), full-time department supervision (OR, 1.60 [95 %CI, 1.02–2.53]) and corresponding regulations (OR, 0.56 [95 %CI, 0.33–0.97]) for patient privacy protection in the hospital, restricted external equipment for computers (OR, 1.76 [95 %CI, 1.10–2.83]), and access to medical records (OR, 0.62 [95 %CI, 0.41–0.94]) were all associated with privacy breaches by physicians.</p></div><div><h3><strong>Conclusions</strong></h3><p>In general, patient privacy research and awareness of patient privacy protection are relatively deficient in China, with a remarkably high occurrence of disclosure. We posit that the identification of the factors underlying our results will provide evidence for appropriate hospital management, and that these factors may then be generalizable to other clinical settings.</p></div><div><h3><strong>Public interest summary</strong></h3><p>Patient privacy breaches seem to be rarely mentioned and addressed regardless of the country, potentially due to its high sensitivity, while this is significant in clinical practice. In this study, we meant to find out the answers to the questions, “What is the situation of privacy disclosure in China public medical institutions?”, “Why does it happen?”, and “Is patient privacy protected enough? If not, how can we do better?”. Through conducting a survey among physicians, their answers were collected for further analysis. Our
目的尽管在临床实践中有可能提高医生和医院管理人员的保护意识,但在公共医疗机构中保护患者隐私的重要性仍未得到充分认识。我们在此设计了一项调查,以调查中国患者隐私泄露的现状,并确定其潜在的理由。方法采用便利抽样和滚雪球抽样的方法,对全国7个地理区域的928名医生进行全面调查,纳入《中国卫生统计年鉴》中定义的医生,并测量医疗数据泄露的发生率。通过描述性统计了解医生对患者隐私保护的认知和行为,以及他们对医院管理的态度。对每个模型进行不同协变量调整的多元logistic回归分析。结果937名应答者中,928名医生符合分析条件。我们估计有52.2% (95% CI, 48.9-55.4)的医生报告说他们泄露了病人的隐私。硕士(OR, 0.63 [95% CI, 0.43-0.92])和博士(OR, 0.59 [95% CI, 0.35-1.00])学历水平,对患者隐私保护的理解得分(OR, 0.89 [95% CI, 0.80-0.99]),是否有经历过数据泄露的同事在场(OR, 7.00 [95% CI, 5.02-9.77]),是否有专职科室监督(OR, 1.60 [95% CI, 1.02-2.53])和相应的医院患者隐私保护规定(OR, 0.56 [95% CI, 0.33-0.97]);限制计算机外部设备(OR, 1.76 [95% CI, 1.10-2.83])和获取医疗记录(OR, 0.62 [95% CI, 0.41-0.94])都与医生侵犯隐私有关。结论总体而言,中国的患者隐私研究和患者隐私保护意识相对不足,患者隐私泄露的发生率很高。我们认为,确定我们的结果背后的因素将为适当的医院管理提供证据,并且这些因素可以推广到其他临床环境。无论在哪个国家,侵犯患者隐私似乎很少被提及和解决,可能是由于其高度敏感性,而这在临床实践中很重要。在本研究中,我们试图找出“中国公立医疗机构的隐私披露情况如何?”、“为什么会这样?”,以及“病人隐私是否得到了足够的保护?”如果不能,我们怎样才能做得更好?”通过对医生进行调查,收集他们的回答以作进一步分析。我们的研究结果似乎为医生在患者隐私保护和支持医院和信息管理方面提供了指导。
{"title":"A national survey of physicians regarding protection of patient privacy in China","authors":"Zhongzhou Xiao ,&nbsp;Wei Zhai ,&nbsp;Xinwei Peng ,&nbsp;Yun Zhong ,&nbsp;Shuqing Luo ,&nbsp;Ruiyao Chen ,&nbsp;Lu Lu ,&nbsp;Yijue Zhang ,&nbsp;Jie Xu","doi":"10.1016/j.hlpt.2023.100823","DOIUrl":"https://doi.org/10.1016/j.hlpt.2023.100823","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;&lt;strong&gt;Objectives&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;The significance of safeguarding patient privacy at a population level within public medical institutions remains insufficiently acknowledged despite the potential to enhance the protection awareness of physicians and of hospital management in clinical practice. We herein devised a survey to investigate the current state of patient privacy breaches in China and to ascertain its underlying rationales.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;&lt;strong&gt;Methods&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;&lt;span&gt;We conducted a comprehensive nationwide survey of 928 physicians in seven geographic regions of China through convenience and snowball sampling, enrolled physicians defined in the Chinese Health Statistics Yearbook, and measured the incidence of medical data breaches. Physicians’ perceptions and behaviors with respect to patient privacy protection and their attitudes toward hospital management were accessed through descriptive statistics. Multiple &lt;/span&gt;logistic regression analysis was also conducted with different adjustments of covariates for each model.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;&lt;strong&gt;Results&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Of the 937 respondents, 928 physicians were eligible and validated for the analysis. We estimated that 52.2 % (95 %CI, 48.9–55.4) of the physicians reported that they had disclosed their patients’ privacy. Master's (OR, 0.63 [95 %CI, 0.43–0.92]) and Ph.D. (OR, 0.59 [95 %CI, 0.35–1.00]) educational levels, scores on the understanding of patient privacy protection (OR, 0.89 [95 %CI, 0.80–0.99]), the presence of colleagues who had experienced data disclosure (OR, 7.00 [95 %CI, 5.02–9.77]), full-time department supervision (OR, 1.60 [95 %CI, 1.02–2.53]) and corresponding regulations (OR, 0.56 [95 %CI, 0.33–0.97]) for patient privacy protection in the hospital, restricted external equipment for computers (OR, 1.76 [95 %CI, 1.10–2.83]), and access to medical records (OR, 0.62 [95 %CI, 0.41–0.94]) were all associated with privacy breaches by physicians.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;&lt;strong&gt;Conclusions&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;In general, patient privacy research and awareness of patient privacy protection are relatively deficient in China, with a remarkably high occurrence of disclosure. We posit that the identification of the factors underlying our results will provide evidence for appropriate hospital management, and that these factors may then be generalizable to other clinical settings.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;&lt;strong&gt;Public interest summary&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Patient privacy breaches seem to be rarely mentioned and addressed regardless of the country, potentially due to its high sensitivity, while this is significant in clinical practice. In this study, we meant to find out the answers to the questions, “What is the situation of privacy disclosure in China public medical institutions?”, “Why does it happen?”, and “Is patient privacy protected enough? If not, how can we do better?”. Through conducting a survey among physicians, their answers were collected for further analysis. Our","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":"12 4","pages":"Article 100823"},"PeriodicalIF":6.0,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134656463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Policy and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1